Equity Method Investment	12 Months Ended
Aug. 31, 2025
Equity Method Investments and Joint Ventures [Abstract]
Equity Method Investment	Note 4 – Equity Method Investment On December 19, 2024, the Company completed its acquisition of a 49.9% non-controlling interest in Pessl Instruments GmbH ("Pessl"), an Austrian company that provides agricultural technology solutions focused on field monitoring systems such as weather stations and soil moisture probes, for $7.5 million, inclusive of direct transaction costs. The acquisition of the non-controlling interest includes a call option that, if exercised, would allow the Company to acquire the remainder of Pessl’s outstanding shares based on Pessl’s future earnings at certain dates in the future, beginning in October 2027. The Company's investment in Pessl is accounted for pursuant to the equity method due to the Company’s ability to exert significant influence over decisions relating to Pessl's operating and financial affairs. Revenue and expenses of this investment are not consolidated into the Company’s financial statements; rather, the proportionate share of the earnings or losses is recorded within other income (expense), net on the consolidated statements of earnings. Earnings or losses are recorded on a one-month lag due to differences in reporting timelines between the Company and Pessl. For the year ended August 31, 2025, the Company recognized $0.4 million in equity earnings, net of amortizable basis differences, from its investment in Pessl. The Company determined that on the date of the minority interest acquisition of Pessl, there were differences between the Company's investment in Pessl and its proportional interest in the equity of Pessl of approximately $0.7 million, which represented basis differences between the Company's purchase price and its share of Pessl's net assets as well as residual equity method goodwill that is not amortized. Amortizable basis differences, which are not financially significant, are being amortized over a 5-year period and are recorded within other income (expense), net on the consolidated statements of earnings.

Equity Method Investment

12 Months Ended

Aug. 31, 2025

Equity Method Investments and Joint Ventures [Abstract]

Note 4 – Equity Method Investment

On December 19, 2024, the Company completed its acquisition of a 49.9% non-controlling interest in Pessl Instruments GmbH ("Pessl"), an Austrian company that provides agricultural technology solutions focused on field monitoring systems such as weather stations and soil moisture probes, for $7.5 million, inclusive of direct transaction costs. The acquisition of the non-controlling interest includes a call option that, if exercised, would allow the Company to acquire the remainder of Pessl’s outstanding shares based on Pessl’s future earnings at certain dates

in the future, beginning in October 2027.

The Company's investment in Pessl is accounted for pursuant to the equity method due to the Company’s ability to exert significant influence over decisions relating to Pessl's operating and financial affairs. Revenue and expenses of this investment are not consolidated into the Company’s financial statements; rather, the proportionate share of the earnings or losses is recorded within other income (expense), net on the consolidated statements of earnings. Earnings or losses are recorded on a one-month lag due to differences in reporting timelines between the Company and Pessl. For the year ended August 31, 2025, the Company recognized $0.4 million in equity earnings, net of amortizable basis differences, from its investment in Pessl.

The Company determined that on the date of the minority interest acquisition of Pessl, there were differences between the Company's investment in Pessl and its proportional interest in the equity of Pessl of approximately $0.7 million, which represented basis differences between the Company's purchase price and its share of Pessl's net assets as well as residual equity method goodwill that is not amortized. Amortizable basis differences, which are not financially significant, are being amortized over a 5-year period and are recorded within other income (expense), net on the consolidated statements of earnings.